Back to search results

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.

Abroad (travel likely)RecruitingPHASE3

Conditions

Multiple Sclerosis · Relapsing-remitting Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer, Lyon, Bron, France

    Contact: Study coordinator (Sandra VUKUSIC, MD) · sandra.vukusic@chu-lyon.fr

  • CHRU de Brest - Hôpital la Cavale Blanche, Brest, France

    Contact: Study coordinator (Aurore JOURDAIN, MD) · aurore.jourdain@chu-brest.fr

  • Centre Hospitalier Universitaire de Caen, Caen, France

    Contact: Study coordinator (Gilles DEFER, MD) · defer-gi@chu-caen.fr

  • Centre Hospitalier de Pontoise - GHT NOVO, Cergy-Pontoise, France

    Contact: Study coordinator (Philippe NICLOT, MD) · philipe.niclot@ght-novo.fr

  • Hôpital Gabriel Montpieds, Clermont-Ferrand, France

    Contact: Study coordinator (Pierre CLAVELOU, MD) · pclavelou@chu-clermont-ferrand.fr

  • Centre hospitalier de Gonnesse, Gonesse, France

    Contact: Study coordinator (Eric MANCHON, MD) · eric.manchon@ch-gonessse.fr

  • Groupe Hospitalier de l'Institut Catholique de Lille, Lille, France

    Contact: Study coordinator (Julien POUPARD, MD) · poupart.julien@ghicl.net

  • Centre Hospitalier Universitaire de Limoges, Limoges, France

    Contact: Study coordinator (Laurent MAGY, MD) · laurent.magy@chu-limoges.fr

  • AP-HM - Hôpital la Timone, Marseille, France

    Contact: Study coordinator (Bertrand AUDOIN, MD) · bertrand.audoin@ap-hm.fr

  • CHRU de Montpellier - Hôpital Gui de Chauliac, Montpellier, France

    Contact: Study coordinator (Pierre LABAUGE, MD) · labauge@yahoo.fr

  • Centre Hospitalier Régional de Nancy, Nancy, France

    Contact: Study coordinator (Guillaume MATHEY, MD) · g.mathey@chrudenancy.fr

  • CHU de Nantes -Hôpital Nord Laennec, Nantes, France

    Contact: Study coordinator (David LAPLAUD, MD) · david.laplaud@chu-nantes.fr

  • CHU de Nice - Hôpital Pasteur 2, Nice, France

    Contact: Study coordinator (Christine LEBRUN-FRENAY, MD) · lebrun.frenay.c@chu-nice.fr

  • CHU de Nîmes - Hôpital Caremeau, Nîmes, France

    Contact: Study coordinator (Eric THOUVENOT, MD) · eric.thounevot@chu-nimes.fr

  • AP-HP Höpital la Pitié-Salpétrière, Paris, France

    Contact: Study coordinator (Céline LOUAPRE, MD) · celine.louapre@aphp.fr

  • Groupe Hospitalier Universitaire Henri Mondor, Paris, France

    Contact: Study coordinator (Alain CREANGE, MD) · alain.creange@aphp.fr

  • Hôpital Saint-Germain, Poissy, France

    Contact: Study coordinator (Olivier HEINZLEF, MD) · oheinzlef@chi-poissy-st-germain.fr

  • Centre Hospitalier de Cornouaille, Quimper, France

    Contact: Study coordinator (Marc COUSTANS, MD) · m.coutains@ch-cornouaille.fr

  • Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France

    Contact: Study coordinator (Laure MICHEL, MD)
    Contact: Principal Investigator (Laure MICHEL, PH-PD)

  • CHU de Rouen - Hôpital Charles Nicolle, Rouen, France

    Contact: Study coordinator (Bertrand BOURRE, MD) · bertrand.bourre@chu-rouen.fr

  • CHRU de Strasbourg - Hôpital Hautpierre, Strasbourg, France

    Contact: Study coordinator (Jérôme DE SEZE, MD) · jerome.de.seze@chru-strasbourg.fr

  • Hôpital Foch, Suresnes, France

    Contact: Study coordinator (TCHIKVILADZE Maia, MD) · m.tchikviladze@hopital-foch.com

  • CHU de Toulouse - Bâtiment Pierre Paul Riquet, Toulouse, France

    Contact: Study coordinator (Jonathan CIRON, MD) · ciron.j@chu-toulouse.fr
View source on ClinicalTrials.gov(opens in a new tab)